Profitability
Weight: 25%
C
51
- 5yr Avg ROIC 4.1%
- Operating Margin Trend +1.89 pp/yr
JAZZ
Jazz Pharmaceuticals plc
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
⚠ 3 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a platform & compounding fcf business.
Grade overrides the 30.0 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
26
- 5yr Avg ROE 0.3%
- 5yr Share-Count CAGR 0.5%
Growth Quality
Weight: 25%
A
89
- 5yr Revenue CAGR 8.4%
- 5yr EPS CAGR 41.8%
- Revenue-Growth Years (5) 5/5
Cash Generation
Weight: 20%
A-
86
- 5yr FCF Margin 27.2%
- 5yr FCF/NI Conversion 2.49x
Balance Sheet
Weight: 10%
F
10
- Net Debt / EBITDA 27.49x
- Interest Coverage (EBIT/Int) -2.22x
- Altman Z-Score 1.91
Stability
Weight: 5%
B
74
- EPS Volatility (σ/μ) 0.25
- Piotroski F-Score 6
- Negative-Revenue Years (5) 0/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.3 of 3 gurus held; 2 added; 1 trimmed.
- Holders
- 3
- Avg Δ position
- +0.6%
- New buys
- 0
- Full exits
- 0
- Wood decreased -97%
- Greenblatt increased +50%
- Cooperman increased +50%